Radiopharm Theranostics, Ltd clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   BetaBart · 177Lu-BetaBart · Relapsed/Refractory, Locally Advanced…BetaBart · 177Lu-BetaBart · Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

   Primary endpoint(s) modified

   Also in this update: Interventions modified

   Radiopharm Theranostics, Ltd·Phase 1/2· NCT07189871· Registry history of NCT07189871 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

2. Notable

   RAD202 · HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

   Primary endpoint(s) modified

   Radiopharm Theranostics, Ltd·Early Phase 1· NCT06824155· Registry history of NCT06824155 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.